This Influenza A IgM Positive Human Serum (Cat# D4214) is a high-quality biological matrix sourced from single human donors confirmed to have Influenza A-specific IgM antibodies. Designed for research and assay development, this serum is ideal for use as a positive control or calibrator in serological and immunoassay workflows targeting early-phase influenza infections.
Confirmed positive for Influenza A IgM antibodies
Derived from single human donors for consistent antibody profile
Free of preservatives and additives for maximum compatibility
Anticoagulated with 4% sodium citrate
Tested and non-reactive for HIV 1/2, HBsAg, HCV, and RPR using FDA-approved methods
Development and validation of Influenza A IgM diagnostic assays
Positive control material for ELISA, CLIA, or lateral flow assays
Use in infectious disease research focused on acute influenza immune response
Quality control and calibration for in-vitro diagnostic kit manufacturing
This Influenza A IgM Positive Human Serum (Cat# D4214) is a high-quality biological matrix sourced from single human donors confirmed to have Influenza A-specific IgM antibodies. Designed for research and assay development, this serum is ideal for use as a positive control or calibrator in serological and immunoassay workflows targeting early-phase influenza infections.
Confirmed positive for Influenza A IgM antibodies
Derived from single human donors for consistent antibody profile
Free of preservatives and additives for maximum compatibility
Anticoagulated with 4% sodium citrate
Tested and non-reactive for HIV 1/2, HBsAg, HCV, and RPR using FDA-approved methods
Development and validation of Influenza A IgM diagnostic assays
Positive control material for ELISA, CLIA, or lateral flow assays
Use in infectious disease research focused on acute influenza immune response
Quality control and calibration for in-vitro diagnostic kit manufacturing
